Estimated read time: 8 minutes. Intended for laboratory researchers evaluating the analytical quality of research peptides for non-human in vitro studies.
Why Purity Matters in Peptide Research
In a peptide-research context, “purity” is a measure of how much of the material in the vial is the intended sequence versus everything else — truncated chains, deletion sequences, oxidized variants, residual reagents from synthesis, and trace solvents. The everything-else category is the source of most reproducibility problems in peptide-based research. A 90%-pure compound and a 99%-pure compound behave very differently in a dose-response curve, even when nominal mass is identical, because the impurity profile can introduce off-target binding, immunogenic responses in cell-line work, or solubility artifacts.
Published peptide research is generally expected to use material at ≥95% purity, and high-resolution studies (binding affinity, receptor kinetics) at ≥98%. AminoCore Labs targets ≥99% HPLC purity across the catalog — see flagship lots for BPC-157, TB-500, Retatrutide, and Tirzepatide.
How HPLC Purity Testing Works
High-Performance Liquid Chromatography is the standard method for measuring peptide purity. A small sample of the dissolved peptide is pushed through a packed chromatography column with a controlled solvent gradient. Molecules in the sample interact differently with the column packing and elute at different times. A detector (usually UV absorbance at 214 nm, which captures the peptide bond) records each peak as the eluent leaves the column.
The output is a chromatogram — a graph of signal intensity over time. The main peak corresponds to the intended peptide; smaller peaks are impurities. Purity is calculated as the area of the main peak divided by the total area under all peaks, expressed as a percentage. A clean ≥99% chromatogram shows one tall, symmetrical peak and very little baseline noise. A ≤90% chromatogram has visible shoulders, broad peaks, or multiple comparable peaks — warning signs that the synthesis was not well controlled.
Mass spectrometry (MS) is the complementary analysis: HPLC tells you how much pure material is in the vial, MS tells you whether that material is the right molecule. A complete COA includes both.
What a Certificate of Analysis (COA) Should Contain
A Certificate of Analysis is a batch-specific document attesting to the analytical identity and purity of a particular lot. For a peptide intended for research use, a complete COA includes:
- Product name and sequence — the chemical identity, written in standard one-letter or three-letter amino-acid notation.
- Lot or batch number — must match the printed label on the vial.
- Molecular formula and molecular weight — calculated theoretical values.
- HPLC purity result — the measured percentage, plus the chromatogram image.
- Mass spectrometry result — observed mass vs. theoretical mass, confirming molecular identity.
- Appearance — physical form (typically white to off-white lyophilized powder).
- Net peptide content — the mass of peptide after accounting for counterions and residual moisture. Important for accurate concentration math.
- Test date — when the lot was analyzed.
- Re-test or expiration date — how long the test data can be relied on before re-verification is recommended.
- Storage instructions — usually 2–8°C, sealed.
A COA that omits the chromatogram or shows only a single self-reported purity number with no supporting trace is not a complete document — it is a claim, not evidence.
Reading a COA: What to Look For
- Confirm the lot number matches your vial. A generic COA labeled with the product name only (no lot) is not batch-traceable and should not be relied on for research data.
- Look at the HPLC chromatogram, not just the headline number. A clean single peak above 99% is what you want. A noisy baseline, broad shoulders, or multiple peaks of similar height mean the headline number is inflated.
- Check that observed MS mass matches theoretical. The two numbers should agree within ~1 Da. A wider mismatch means the molecule in the vial is not exactly what the label says.
- Note the test date. A COA from two years ago for material that has been sitting on a shelf since synthesis is less reliable than a fresh one. Many labs re-test after 12–24 months.
- Note the net peptide content. A vial labeled “5 mg” with a net peptide content of 4.0 mg means 1.0 mg of that mass is counterion (typically trifluoroacetate) and residual water. Concentration math should be based on net peptide, not gross vial weight, for dose-response work.
≥95% vs ≥99% — Does the Extra 4 Percent Matter?
For exploratory cell-culture work or pilot studies, ≥95% material is usually adequate. The impurity profile at that level is typically truncated sequences from the same synthesis, which are unlikely to introduce qualitative artifacts.
For binding-affinity studies, receptor kinetics, structure-activity comparisons across analogues, or any work where another lab will need to reproduce the result, ≥99% becomes important. The reason is that the 4-percent gap is not a small thing — in a 1 mg/mL preparation it represents 40 mcg/mL of unknown contaminant, which is more than enough to confound a low-nanomolar dose-response measurement.
AminoCore Labs defaults to ≥99% HPLC across the catalog because the cost differential at synthesis is small compared to the cost of a research result that fails to replicate.
Batch Testing vs. Spot Testing
There are two patterns in peptide-supplier COA practice:
- Per-batch testing. Every production lot is tested independently and gets its own COA. This is the gold standard — the COA you receive describes the exact material in your vial.
- Spot testing. A supplier tests one batch per quarter (or per year) and applies the result to all subsequent lots. This is faster and cheaper but provides no traceability for any specific vial — the COA is more marketing document than analytical record.
For research that may be published, spot-tested material is generally not acceptable. AminoCore Labs maintains per-batch COAs in the COA Archive; lookups by lot number return the document that applies to your specific vial.
Third-Party vs. In-House COA Verification
In-house testing means the supplier ran the HPLC themselves. Third-party testing means an independent analytical lab (e.g. Janoshik Analytical, MZ Biolabs) re-tested a representative sample and issued an independent report. Third-party verification is the stronger signal because the testing entity has no commercial interest in the result.
For new suppliers, asking whether they will provide a third-party COA on request is a reasonable due-diligence step. For repeat purchases, a track record of consistent in-house COAs that match third-party spot checks is sufficient for most research applications.
Practical Checklist Before Running an Experiment
- Lot number on the vial matches lot number on the COA.
- HPLC chromatogram shows a single sharp peak with ≥99% area (or ≥95% for pilot work).
- MS observed mass agrees with theoretical within 1 Da.
- COA test date is within the supplier’s stated re-test window.
- Net peptide content is documented and used for concentration math.
- Storage history of the vial is known (refrigerated, light-protected, sealed).
If any item fails, the safer path is to verify the lot independently or request a fresh batch before committing experimental resources.
Companion Reading
Once you have verified the lot, the next step is reconstitution. See our companion guide: Peptide Reconstitution Guide for Laboratory Research.
Disclaimer
FOR RESEARCH USE ONLY. The analytical practices described in this guide apply to research peptides used in in vitro laboratory studies in non-human models. AminoCore Labs research peptides are not intended for human consumption, veterinary use, diagnostic use, or any therapeutic application. None of the compounds discussed are approved by the FDA for use in humans. This article is informational reference material for laboratory professionals and does not constitute medical, veterinary, or clinical guidance.